Taken together, these disease-focused studies reveal putative roles for ATXN2 in processes that are deregulated in several diseases including PD, SCA1, MJD, tauopathies, POAG and obesity/type I diabetes (Figure 3). The gene discussed is ATXN2; the disease is obesity due to melanocortin 4 receptor deficiency.